Access cutting-edge migraine treatment through this clinical trial at a research site in Grand Island. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Grand Island location
Preparing your pre-screening questions…
Access migraine specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related migraine treatment provided free
Check if you qualify for this migraine clinical trial in Grand Island, NE
No-Cost Study Care
Local to Grand Island
Convenient for NE residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Migraine is a neurological disease characterized by moderate or severe headaches, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess changes in migraine attack severity for adult participants treating with oral ubrogepant across migraine attacks. Ubrogepant is a drug that is approved for the acute treatment of migraine in adults. Approximately 189 participants will be enrolled in approximately 15 sites across the US. Participants will receive ubrogepant as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 13 weeks. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Sponsor: AbbVie
Yes, this clinical trial (NCT07310290) has an active research site in Grand Island, NE that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for migraine treatment options in Grand Island, NE, this clinical trial (NCT07310290) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Grand Island research site is actively enrolling participants for this clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all migraine clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Grand Island — not just this study.
Browse Heart Attack Trials in Grand Island →